TGTX Operating Income Growth
Tg Therapeutics Inc · Operating Income Growth
TGTX Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported58.80%period ending
TGTX TTM Operating Income YoY % (-82.14% → 58.80%)
Year-over-year change
High-resolution chart · PNG
TGTX operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| 58.8016% | |
| 149.9072% | |
| 194.1258% | |
| 20,452.2772% | |
| -15.7072% | |
| 23.7121% | |
| 103.2133% | |
| 97.3342% | |
| 160.3737% | |
| 129.6733% | |
| 110.6997% | |
| 91.8947% | |
| 40.5783% | |
| 49.4608% | |
| 44.0675% | |
| 30.9745% | |
| 16.3061% | |
| -3.1636% | |
| -26.0148% | |
| -50.6433% | |
| -69.6745% | |
| -69.3034% | |
| -61.8382% | |
| -21.3383% | |
| -25.9591% | |
| -10.207% | |
| 3.0654% | |
| -22.4473% | |
| -6.8459% | |
| -26.3075% | |
| -46.9105% | |
| -35.4323% | |
| -41.4075% | |
| -43.1536% | |
| -50.3268% | |
| -53.9039% | |
| -70.8577% | |
| -48.0652% | |
| -24.9907% | |
| -12.9471% | |
| 9.4199% | |
| 0.2384% | |
| -13.3862% | |
| -42.8796% | |
| -110.8977% | |
| -133.5281% | |
| -142.6244% | |
| -140.759% | |
| -92.1694% | |
| -103.0967% | |
| 14.609% | |
| 18.5512% | |
| 18.2375% | |
| 25.2946% | |
| -2,949.4208% | |
| -1,335.8086% | |
| -1,006.4913% | |
| -762.0556% | |
| 56.2673% | |
| 16.4314% | |
| -3.3321% | |
| -17.762% | |
| -13.8397% | |
| -38.7164% | |
| 24.2784% | |
| 48.0419% | |
| 59.8532% | |
| 78.4141% | |
| 69.3026% | |
| 69.9397% | |
| 63.6634% | |
| 52.3795% | |
| 39.1402% | |
| -10.5654% | |
| -16.5769% | |
| -35.7259% | |
| -29.5797% | |
| 51.4886% | |
| 46.1842% | |
| 46.6378% | |
| 48.2611% | |
| -221.3215% | |
| -215.1158% | |
| -215.2486% | |
| -233.2387% | |
| -18.6669% | |
| -29.0956% | |
| -62.8895% | |
| -163.1669% | |
| -305.6819% | |
| -206.4143% | |
| -106.593% | |
| -15.7397% | |
| 60.0211% | |
| 48.0175% | |
| -1,457.7557% | |
| -401.7027% | |
| -68.6708% | |
| 5.5372% | |
| 98.1578% |